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Design patternsa b s t r a c t
Background: Design patterns, in the context of software development and ontologies, provide generalized
approaches and guidance to solving commonly occurring problems, or addressing common situations
typically informed by intuition, heuristics and experience. While the biomedical literature contains broad
coverage of speciﬁc phenotype algorithm implementations, no work to date has attempted to generalize
common approaches into design patterns, which may then be distributed to the informatics community
to efﬁciently develop more accurate phenotype algorithms.
Methods: Using phenotyping algorithms stored in the Phenotype KnowledgeBase (PheKB), we conducted
an independent iterative review to identify recurrent elements within the algorithm deﬁnitions. We
extracted and generalized recurrent elements in these algorithms into candidate patterns. The authors then
assessed the candidate patterns for validity by group consensus, and annotated them with attributes.
Results: A total of 24 electronicMedical Records andGenomics (eMERGE) phenotypes available in PheKB as
of 1/25/2013 were downloaded and reviewed. From these, a total of 21 phenotyping patterns were identi-
ﬁed, which are available as an online data supplement.
Conclusions: Repeatable patterns within phenotyping algorithms exist, and when codiﬁed and cataloged
may help to educate both experienced and novice algorithmdevelopers. The dissemination and application
of these patterns has the potential to decrease the time to develop algorithms, while improving portability
and accuracy.
 2014 Elsevier Inc. All rights reserved.1. Introduction
Electronic health records (EHRs) have been shown to be a valu-
able source of information for biomedical research, including the
deﬁnition and identiﬁcation of clinical phenotypes [1–5]. The
increasing use of EHRs [6,7] has resulted in large quantities of data
available for secondary purposes such as research. In order to bet-
ter handle this growing source of data, we need to improve meth-
ods and approaches to phenotype more efﬁciently.The electronic Medical Records and Genomics (eMERGE) net-
work has been a leader in the development of phenotype algo-
rithms based on EHR data. In addition to the work done through
eMERGE for genome-wide association studies (GWAS) [8–15],
there are additional examples of electronic algorithms to mine
EHRs for identifying diseases for biomedical research and clinical
care [16–20] disease surveillance [21], pharmacovigilance [22], as
well as for decision support [23]. These studies have provided
some guidance on dealing with the challenges of using EHR and
claims data [2,20,24–26]. This guidance has often been in the con-
text of a single algorithm, although more recent work has begun to
address the broader challenges of using EHR data for phenotyping
[1,27]. Additionally, research is being conducted to identify how
electronic phenotype algorithms may be represented and
made more portable across disparate EHRs [28,29], which has the
Fig. 1. Methods for developing and reviewing phenotype design patterns.
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nuances of EHR data.
A major goal of the current phase of eMERGE is to improve the
ease and speed of developing new phenotype deﬁnitions. No
known work to date, however, has attempted to broadly classify
challenges and solutions to using EHR data for the development
of electronic phenotype algorithms, or demonstrated an approach
to widely disseminate the ﬁndings. This knowledge could poten-
tially reduce the time to develop phenotype algorithms, improve
portability to other sites and even accuracy by describing experi-
ences developing other algorithms. The primary goal of this paper
is to apply lessons from prior work in software design patterns to
the problem of deﬁning and disseminating EHR-based phenotype
algorithms.
In software engineering, the use of design patterns are frequently
used to generate solutions to common problems or scenarios [30].
These patterns are free from any technical implementation details,
such as programming language or database platform. Design pat-
terns are not applicable only in the domain of software develop-
ment. They have roots in architecture [31], and have recently been
applied to the development of ontologies [32,33] and health infor-
mation technology (HIT) solutions [34,35]. Even though design pat-
terns are used in multiple domains, they share similar constructs
that form a basis of overall pattern languages [36]. Generally, design
patterns provide: (1) a description of a scenario or problem that
exists and that the pattern may address; (2) a template for a solu-
tion; and, (3) considerations for when to apply the pattern, or what
its implicationsmay be [30,31,36]. Design patterns are not intended
to capture every possible pattern that may occur in the target
domain; rather, they represent best practices and common
approaches to solving a problem. In practice, they may be derived
from intuition, heuristics and experience.
In order to more widely disseminate solutions to common prob-
lems and scenarios found in the development of electronic pheno-
type algorithms, we propose the creation of ‘‘EHR-driven
phenotype extraction design patterns’’—logical patterns recurring
frequently in phenotyping algorithms that are EHR and technology
agnostic. This paper presents an initial catalog of such patterns
from experiences within the eMERGE network.2. Methods
The steps used to deﬁne, develop and review phenotype design
patterns are shown in Fig. 1, and are explained in more detail
below.
2.1. Setting
The eMERGE network [37] is a National Human Genome
Research Institute (NHGRI)-sponsored initiative that has demon-
strated the feasibility of EHR-derived phenotypes in order to
conduct genome-wide association studies (GWAS). Within the net-
work, sites develop and locally validate an EHR-based phenotype
algorithm, which are then implemented and validated at one or
more additional network sites. While phenotype algorithms them-
selves are largely recorded as text documents [38] and have to be
re-implemented in a format that can be executed at each site, the
transfer of phenotypes from one site to other sites with different
EHR systems demonstrates the broader application of EHR-derived
phenotyping.
2.2. Phenotype selection
Phenotypes created by the eMERGE network are publicly avail-
able on the Phenotype KnowledgeBase website (PheKB, http://www.phekb.org), and are classiﬁed by the group or consortium
under which the algorithm was created, as well as a status to indi-
cate how mature the algorithm is in its development process. For
this study, all phenotype algorithms associated with the eMERGE
network that were marked with a ‘‘Final’’ or ‘‘Validated’’ status
were downloaded on January 25, 2013. The algorithm set consists
of both case/control studies (i.e. Cataracts, Resistant Hypertension)
as well as quantitative measures (i.e. Red Blood Cell Indices, White
Blood Cell Indices). The algorithms were developed, implemented,
and validated by chart review by at least one other eMERGE site.
Phenotypes that were available in PheKB but had not been
validated were considered too preliminary for study, and were
excluded. In addition, the selected algorithms within the eMERGE
network were not developed independently (sites collaborated
on and built new algorithms after having reviewed others), which
allowed evaluation of shared experiences as algorithms were
developed over time.
2.3. Phenotype algorithm review
One of the authors (LVR) reviewed each of the phenotype algo-
rithms, and identiﬁed unique, discrete fragments in the text deﬁni-
tions that represented the inputs, logic, and constraints within the
algorithms. As multiple artifacts can exist for each phenotype algo-
rithm (i.e. chart abstraction forms for validation, data dictionary
deﬁnitions), only documentation containing a textual description
of the algorithm was reviewed.
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where we identiﬁed short text fragments that represent distinct
constructs of the algorithm deﬁnition. There are various forms of
these constructs, such as the sources of data, temporal criteria
and Boolean combinations. We extracted these fragments and
annotated them with a set of tags to denote the context and use
of that fragment in the algorithm. The list of tags was dynamically
created as new examples were encountered. In addition, given the
repeated nature of types of fragments within an algorithm, only
distinct fragments were extracted, and subsequent repeats or sim-
ilar fragments were ignored. The intent was to study distinct
examples per algorithm, and the selection and use of fragments
and their tags were used by reviewers independently to aid in
identifying candidate patterns. Fig. 2 shows as an example the
fragments identiﬁed in a single phenotype algorithm and the con-
textual tags applied.2.4. Identifying phenotyping patterns
Once we coded all of the algorithms, one of the authors (LVR)
iteratively reviewed the list of fragments for repeating categories,
which represent candidate patterns. If a potential candidate pat-
tern was identiﬁed, we sought additional supporting examples in
the list of fragments. We accepted a candidate pattern only if it
was present in two or more algorithms, to better represent that
the approach was repeated and generalizable. The fragment review
process was iterative, using the initial contextual tags as high-level
categories. Sub-categories were created ad-hoc by subjective
assessment of the reviewer, given speciﬁc details of the fragments,
and new sub-category tags added where identiﬁed, with sub-
categories representing candidate patterns. This process was
performed on the full list of fragments until no new candidate pat-
terns were identiﬁed. We then created a template for phenotyping
patterns, based on typical representations for software and other
design patterns. Table 1 shows the ﬁelds in this template.
The candidate patterns were subsequently reviewed by WKT,
JAP, ANK, DSC, JP, PLP and GT. Reviewers independently voted to
approve, tentatively accept, or reject each candidate pattern, pro-
vide justiﬁcation for tentative acceptance or rejection, and to also
provide recommendations to improve or clarify the patterns. Level
of agreement between the seven reviewers on the initial vote was
measured by Gwet’s AC1 [39]. Reviewers, given their collectiveFig. 2. Example annotation and tagging of fragments within the eMERGE Hypoexperience with developing phenotype algorithms, were also
asked to recommend any candidate patterns (following the tem-
plate ﬁelds shown in Table 1) that they felt should exist and were
not included. This expert-based heuristic assessment was used to
complement the single-reviewer, example-based approach used
to create the initial candidate pattern list. Recommended patterns
from the reviewers were assessed against the list of fragments to
see if there were supporting examples. Comments and votes from
the reviewers were consolidated, and majority-rejected patterns
removed. The remaining patterns were considered the list of
approved patterns, and their content iteratively reﬁned by all
authors.
To further correct for potential bias of a single reviewer, the
methods were repeated by another author (WKT). Given the
reviewer’s involvement in the group review process, the intent of
this supplemental review was primarily to account for missed pat-
terns and further reﬁne patterns given new evidence. The second
reviewer iteration also started with the identiﬁcation of fragments
from the phenotype algorithm documents, followed by an iterative
review to create candidate patterns, and included a joint reconcil-
iation process with the ﬁrst reviewer to determine if candidate
patterns were represented in the ﬁrst set, or constituted a new
pattern. Following this supplemental review process, all authors
performed a ﬁnal review and reﬁnement step to arrive at the ﬁnal
list of approved patterns.3. Results
In total, 24 eMERGE algorithms from PheKB marked as ‘‘Final’’
or ‘‘Validated’’ were reviewed. The list of algorithms reviewed is
shown in Table A1 of the online data supplement. For these algo-
rithms, the initial reviewer identiﬁed 340 fragments. Of the 340
fragments, 35.6% (n = 121) of the fragments were selected, having
met the selection criteria. These selected fragments were used as
evidence to construct an initial set of 19 candidate patterns. The
initial level of agreement between the 7 reviewers on acceptance
of the candidate patterns was 69.7%. No candidate patterns were
rejected at the end of the review process. In the course of the group
review, one new pattern was recommended by reviewers, with
supporting examples found amongst the 24 phenotype algorithms.
The secondary reviewer produced 402 fragments, from which 14
candidate patterns were identiﬁed. From this set, 13 were deemedthyroidism phenotype algorithm (available from http://www.phekb.org).
Table 1
Fields used to deﬁne phenotyping patterns.
Field Description
Name An abbreviated name to identify the pattern
Description A description of the approach to take to address a scenario encountered in electronic phenotyping
Reasoning An explanation of why the pattern’s approach is used. This helps to provide additional context on the complexities of EHR data
Examples Example text fragments that represent solutions to address the problem, or particular scenario
Considerations when to use Speciﬁc scenario(s) under which the pattern should be considered for use
Considerations when not to use Speciﬁc scenario(s) under which the pattern may not be needed, or may not be appropriate to use
Related to Other patterns that this pattern is related to, as well as a brief description of the relationship
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included a new pattern not previously identiﬁed. The second
reviewer did not explicitly identify all used fragments, and so no
usage statistics from the second review are reported.
In total, 21 phenotype patterns were identiﬁed, and were placed
into one of ﬁve categories. The list of pattern names, with abbrevi-
ated descriptions and associated beneﬁts, is shown in Table 2. The
full listing of patterns is available as an online data supplement.
All of the reviewed phenotype algorithms implemented at least
one pattern, with the High-Density Lipoproteins (HDL) algorithm
having the most patterns (n = 10). Across all of the 24 reviewed
algorithms, there was an average of 5 patterns per algorithm
(standard deviation 2.7). For the 21 identiﬁed phenotype design
patterns, there was an average of 5.7 algorithms that implemented
each pattern (standard deviation 2.8), with the ‘‘Rule of N’’ pattern
identiﬁed in 13 of the 24 algorithms, and the ‘‘Composition of
Algorithms’’ and ‘‘Ad Hoc Categories’’ patterns being identiﬁed in
the minimum two algorithms. A listing of all phenotype design
patterns and the phenotype algorithms they are found in is avail-
able in Table A2 of the online data supplement.4. Discussion
Our major ﬁnding is that identiﬁable design patterns occur fre-
quently in phenotype algorithms. We have identiﬁed and validated
21 unique phenotype design patterns, which we have deﬁned to
be: (a) present in two or more separate phenotype algorithms
(recurring), (b) free of any EHR, institution or technology speciﬁc
details (generalizable), and (c) applicable in certain situations, with
guidance on when to use (contextual). This afﬁrms experimentally
what has been believed anecdotally in the phenotyping commu-
nity—that, while each phenotype may be unique, effective pheno-
type algorithms frequently contain similar patterns of clinical
variables. Furthermore, this is consistent with the concept of
design patterns in general—identifying solutions where a feeling
of ‘‘deja-vu’’ exists around a problem [30].
The need for phenotype design patterns stems from the
challenges of using EHR data. The EHR is not always an explicit rep-
resentation of the patient’s health at a point in time, due in part to
limited data collected or lack of context surrounding its interpreta-
tion [27,40]. One lesson from eMERGE is that the process of devel-
oping a phenotype algorithm is best done as an iterative process,
involving a diverse team that understands how the information
is captured clinically, how it is represented by the EHR, and how
that data should be extracted and interpreted. In the course of
developing these phenotype algorithms, eMERGE sites typically
describe the pros and cons of different approaches they took in
order to prevent other sites from making similar mistakes, or to
save them time in arriving at an optimal approach.
As an example, the Height phenotype algorithm was noted as
implementing the Multi-Mode Sources, Account for Data Outliers
and Temporal Dependencies patterns. Brieﬂy, the Height algorithm
is looking for adult height measurements for patients that wouldbe unaffected by factors such as disease or medication. The
Multi-Mode Sources pattern was employed to use both structured
data and NLP. The use of NLP was recommended to more accu-
rately identify vertebral compression fractures, for which ICD-9
codes did not adequately cover. The Account for Data Outliers
pattern was applied to correct for data errors in the EHR, such as
inches being recorded in a ﬁeld designated for centimeters (50 in.
recorded as 50 cm). Finally, the Temporal Dependencies pattern
was applied to exclude height measurements that followed an
event that would affect height (i.e. lower limb amputations) and
confound analysis if included.
As with design patterns in other domains, the phenotype design
patterns presented here represent a level of subjective assessment,
although rooted in the review of actual phenotype algorithms.
Invariably, there will be some disagreement on what constitutes
a phenotype pattern, and what constitutes ‘‘common sense’’ or a
basic approach to phenotype algorithm development (similar dis-
agreements exist in the software development community [41]).
This was demonstrated by the lower rate of agreement for
acceptance of certain patterns amongst the reviewers, with several
comments raised if a pattern was too simple. For example, at face
value ‘‘Composition of Algorithms’’ may appear to recommend the
creation of reusable functions—novice common practice in soft-
ware development. However, upon closer inspection, the intent
of that pattern prescribes consideration for reuse in the develop-
ment process (much less commonly done), and closer inspection
to identify previously hidden ‘‘sub-algorithms’’ that may be
extracted, reﬁned and curated for reuse. The descriptions associ-
ated with the proposed phenotype design patterns attempt to
justify why the pattern exists, but may require reﬁnement or
expansion over time.
Many of the proposed design patterns represent different levels
of abstraction with how they may be applied. For example, the
‘‘Composition of Algorithms’’ pattern describes strategies for how
an algorithm would be structured. The ‘‘Rule of N’’ pattern is
applied directly within the algorithm logic. While no formal classi-
ﬁcation scheme is proposed to address this within our study, gen-
eral categories (which are used in online supplement) can provide
a logical grouping.
In addition, as with other design patterns, some of the patterns
are closely related, possibly representing a speciﬁc instantiation of
a pattern for a type of clinical information, or multiple patterns
often being used in conjunction. For example, during the review
process, the ‘‘Conﬁrm Variable Was Checked’’ pattern—which
establishes reasonable evidence that a clinical measure would be
recorded—was initially seen as simply checking if something exists
(a very basic operation). The justiﬁcation given for this pattern is
that while the output is a Boolean indicator, it provides speciﬁc
guidance on how to assess multiple sources of information
(encounters, appointments, physician details, departments, etc.)
to arrive at that decision.
The phenotype algorithms selected for review were speciﬁc to
the eMERGE network, and were intended to identify phenotypes
for GWAS. Algorithms developed for different use cases might have
Table 2
List of phenotyping patterns derived from a review of 24 eMERGE phenotype algorithms.
Pattern name Description Beneﬁts
Anchor date Deﬁne a static date around which all queries and
validations are anchored
Makes results reproducible, such that ongoing changes
in a person’s disease state do not invalidate existing
validations
Composition of algorithms Using an algorithm that was created and validated as a
component of another algorithm
Promotes creation and reuse of validated phenotypes to
be used in other phenotypes, without re-creating, or
using sub-optimal, deﬁnitions
Consolidate multiple values For quantities represented by repeated or multiple
measures, provide a single computed value to represent
the multiple values
Simpliﬁes analysis and the amount of data that needs to
be managed
Account for data outliers Filter out noisy or incorrect values to help ensure
calculations (including average) are not skewed
Improves accuracy of the phenotype deﬁnition
Ad hoc categories Group codes, medications, etc. into ad hoc categories
that are not part of a standard terminology or protocol
Simpliﬁes the deﬁnition of a phenotype algorithm
Multi-mode sources Account for information collected in multiple formats or
sources across an EHR over time
Can improve accuracy of the phenotype deﬁnition by
including all sources of data where information may
solely be recorded
Established patient Make sure the patient is seen within the healthcare
system at a regular enough basis so that the information
pertinent to the algorithm would be on record
Improves accuracy by making sure enough data is
present to make an accurate determination about
disease state
Conﬁrm variable was checked Make sure the patient has been seen by a healthcare
professional, and that the encounter would be sufﬁcient
enough to measure the absence or presence of a disease
or other observation
As patients who are not checked for a disease may in fact
have that disease, which could confound analyses,
ensures that patients have been checked
Qualiﬁers for evidence Require additional qualiﬁers, such as severity, to exist
before accepting a clinical observation
May improve accuracy, and also allows for stratiﬁcation
of disease based on its progression, state, and/or severity
Rule of N Require at least N independent pieces of evidence
substantiating a condition or event to reduce the chance
that extraneous or incidental data is over interpreted as
indicating the condition or event is present
Improves accuracy by correcting for data that could have
been recorded without sufﬁcient context
Use distinct time intervals When requiring a count of items, make sure they happen
on different dates and/or times, optionally with some
time interval between them
Allows for a more speciﬁc phenotype deﬁnition by
setting a time window in which a disease should have
progressed, or ensures that observations are spaced
apart to indicate an ongoing condition
Credentials of the actor Require that a person with appropriate authority (e.g., a
physician with speciﬁc credentials or practicing in a
particular specialty department) recorded the clinical
data
Increases conﬁdence or precision in a diagnosis if a
specialist has recorded it
Establish assertion status Determine if assertion qualiﬁers affect the meaning of
medical observations (e.g., the meaning of assertions
about ‘‘cough’’ vary depending on whether they are
qualiﬁed by negation, uncertainty, hypothetical,
historical references)
Improves accuracy by establishing context around
observations
Medications likely taken Require more assurance that a patient was actually
taking the medication, such as through claims data or
having multiple prescriptions over time
Improves accuracy of phenotypes that rely on
medication usage to conﬁrm absence and/or presence of
the phenotype
Medication details When checking for medications, it may be necessary to
look at dose, frequency and/or route
Allows more precise deﬁnition of phenotype where
medication attributes are important
Evolving reference standards Use ranges of dates in which vocabulary codes or lab
ranges are valid, if the underlying standards are known
to have changed
Increases accuracy of the phenotype by ensuring the
right code is used
Transient condition caveats For patients having transient conditions (e.g.,
pregnancy), take into account how those transient
conditions may alter the interpretation of proximal
clinical observations
Improves accuracy of analysis by removing variables
that may be confounded by some condition
Medical setting of action Explicitly require that data be collected (or not be
collected) in a particular setting of interest (i.e. inpatient,
outpatient)
Improves accuracy of the phenotype by using the
encounter setting to add context to the interpretation of
an observation
Context of evidence Consider the context or setting in which a clinical
observation is made. For example, when interpreting
clinical text mentions of particular conditions, take into
account how its interpretation may vary depending on
the section of a report in which it appears (e.g., Past
Medical History, Problem List, or Family History)
Improve accuracy by looking at the context of how
something is recorded
Temporal dependencies Consider the relationship over time between different
events and/or ages at which events occurred
Provides more complete phenotype deﬁnitions where
progression and temporal dependencies are important
Inception of condition Explicitly deﬁne the date to use when determining the
onset of a condition using multiple sources of
information (medications, labs, diagnosis codes)
Provides consistency in the results of a phenotype
algorithm
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complexity. However, these represent phenotypes spanning a vari-
ety of disease types and implemented across multiple institutions
against a variety of vendor and home-grown EHRs. While it is
possible that phenotype algorithms developed by other institu-tions, or algorithms developed for other purposes may differ, the
algorithms represented a reasonable sample of data types
extracted from diverse EHRs. Also, the assignment of design pat-
terns always involves an inherent level of subjectivity. The require-
ment that examples (represented by the document fragments)
L.V. Rasmussen et al. / Journal of Biomedical Informatics 51 (2014) 280–286 285exist in at least two algorithms for candidate patterns was one
approach to account for this, and the resulting patterns were
reviewed by a panel of domain experts who were intimately famil-
iar with the phenotype algorithms, having developed and/or
implemented these algorithms at their respective sites. As a result,
every algorithm and pattern mapping was vetted by two or more
experts familiar with the algorithm. However, the initial use of a
single reviewer is a limitation. Although another reviewer did
replicate the methods and identiﬁed a new phenotype pattern, it
was done after the group review process, which would bias the
overall collection of patterns found by the second reviewer. This
represents one approach to identifying phenotype algorithm pat-
terns and other techniques warrant exploration, such as the Delphi
method to avoid potential bias.
The optimal use of design patterns in phenotyping deserves
some discussion. While we observed variability in the number of
design patterns used in each phenotype algorithm reviewed, and
that each algorithm in our sample contained at least one pattern,
there is no prescriptive number of phenotype design patterns that
should be applied when developing an algorithm. In any domain,
patterns may be used at inappropriate times due to inexperience
or by cognitive biases [42,43]. It is important to understand the
context in which a pattern should be applied, and be able to justify
why a pattern was applied. It is recommended that the pattern
deﬁnition be read in its entirety, and consideration given if the sce-
narios described by the pattern seem applicable to the situation at
hand. Also, the creation of phenotype algorithms is an iterative
process, and in some cases patterns should only be applied after
initial versions of the algorithm deem it necessary (e.g., adopt a
Rule of N only if single observations introduce excessive false posi-
tive error). Finally, conducting validations during the development
of phenotype algorithms is strongly encouraged as a best practice
[44], and will help to further validate how a phenotype design pat-
tern may improve results, quantify the amount of improvement it
offers, or reveal when marshaling a particular pattern may be
appropriate.
5. Conclusion
Existing EHR-based phenotype algorithms reﬂect a wealth of
experience and knowledge about the secondary use of EHR data.
The development of a list of phenotype design patterns based on
existing phenotype algorithm deﬁnitions from the eMERGE
network should help both novice and experienced data analysts
navigate the nuances and complexities of working with EHR data
for algorithm development. Their use also has the potential to con-
serve algorithm development time while improving accuracy and
portability. The set of patterns presented here is intended as a
starting point for articulating and documenting generalizable pat-
terns useful in phenotype development, and we expect members of
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